GKWIM
FLGT icon

Gerber Kawasaki Wealth & Investment Management’s Fulgent Genetics FLGT Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-81
Closed -$16K – 562
2021
Q3 		$16K Buy
+81
New +$7.36K ﹤0.01% 554
2021
Q2 		– Sell
-3
Closed -$8K – 266
2021
Q1 		$8K Sell
3
-38
-93% -$3.92K ﹤0.01% 224
2020
Q4 		$55K Buy
+41
New +$1.71K 0.01% 175

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's FLGT Position: Q3 2022 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 9,706 shares — an estimated $529K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in FLGT in Q4 2020 and held it in 7 quarters. The position peaked at $7.07M in Q3 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 9,706 Fulgent Genetics shares in Q3 2022, an estimated $529K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Fulgent Genetics in Q4 2020 and held it in 7 quarters.
  • Gerber Kawasaki Wealth & Investment Management's Fulgent Genetics position peaked at $7.07M in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.